MANUEL
GUZMÁN PASTOR
Catedrático de universidad
Instituto Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto Cajal (8)
2024
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783
2020
-
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure
Neuropsychopharmacology, Vol. 45, Núm. 5, pp. 877-886
2011
-
Prospects for cannabinoid therapies in basal ganglia disorders
British Journal of Pharmacology, Vol. 163, Núm. 7, pp. 1365-1378
2005
-
Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation
Journal of Neuroscience, Vol. 25, Núm. 8, pp. 1904-1913
-
The role of cannabinoids in preventing the neurodegenerative process occurring in Alzheimer's disease
Drugs of the Future, Vol. 30, Núm. 8, pp. 807-814
2002
-
Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway
Journal of Biological Chemistry, Vol. 277, Núm. 39, pp. 36527-36533
2001
-
Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor
Cancer Research, Vol. 61, Núm. 15, pp. 5784-5789
1999
-
The AMP-activated protein kinase is involved in the regulation of ketone body production by astrocytes
Journal of Neurochemistry, Vol. 73, Núm. 4, pp. 1674-1682